Literature DB >> 1064852

Structural and kinetic studies of lasalocid A (X537A) and its silver, sodium, and barium salts in nonpolar solvents.

D J Patel, C Shen.   

Abstract

The ionophore lasalocid A (X537A) and its metal salts have been investigated by high resolution (270 MHz and 360 MHz) proton nuclear magnetic resonance spectroscopy to obtain structural and kinetic information in nonpolar solution. The proton resonances were assigned from double resonance studies on lasalocid A and on its salts, homologs, isomers, and chemically modified derivatives. Studies of proton and carbon longitudinal relaxation time suggest that lasalocid A exists as a monomer, whereas the sodium and barium salts exist as dimers in nonpolar solvents. A study of the magnitude of the vicinal proton coupling constants and the chemical shifts and linewidths of the hydroxyl resonances suggest that the backbone conformation and intramolecular hydrogen bonds are similar for lasalocid A and its sodium and barium salts in nonpolar solvents. Nuclear magnetic resonance studies on the role of bound solvent molecules suggest a tightly bound water molecule in the barium complex dimer (crystallized from water-ethanol) and a weakly bound ethanol molecule in the lasalocid A monomer (crystallized from ethanol) in cyclohexane. The selective changes in proton chemical shift on complexation [where the polar faces of two lasalocid anions coordinate the metal cation(s) in nonpolar solvents have been analyzed in terms of the proximity of the resonances to the cation, their linkage to the coordinating oxygen atoms, and the magnetic anisotropy effects of the polar groups of one ligand on the resonances of its partner in the dimer. The nuclear magnetic resonance studies in solution are compared with earlier observations on lasalocid A and its salts in the crystalline state. Thus, the short Ag-C5 distance in the crystal structure of silver complex dimer is also observed in the solution structure. The kinetic parameters associated with the exchange between lasalocid A and its barium complex in chloroform have been measured from an analysis of the resonance line shapes as a function of temperature.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1064852      PMCID: PMC430389          DOI: 10.1073/pnas.73.6.1786

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  X537A: a Ca2+ ionophore with a polarity-dependent and complexation-dependent fluorescence signal.

Authors:  D H Haynes; B C Pressman
Journal:  J Membr Biol       Date:  1974       Impact factor: 1.843

2.  Ion binding by X-537A. Formulas, formation constants, and spectra of complexes.

Authors:  H Degani; H L Friedman
Journal:  Biochemistry       Date:  1974-11-19       Impact factor: 3.162

3.  Pulsed NMR methods for the observation and assignment of exchangeable hydrogens: application to bacitracin.

Authors:  I D Campbell; C M Dobson; G Jeminet; R J Williams
Journal:  FEBS Lett       Date:  1974-12-01       Impact factor: 4.124

4.  Chemical transformations of antibiotic X-537A and their effect on antibacterial activity.

Authors:  J W Westley; E P Oliveto; J Berger; R H Evans; R Glass; A Stempel; V Toome; T Williams
Journal:  J Med Chem       Date:  1973-04       Impact factor: 7.446

5.  Proton magnetic resonance detection of ionophor mediated transport of praseodymium ions across phospholipid membranes.

Authors:  M S Fernández; H Célis; M Montal
Journal:  Biochim Biophys Acta       Date:  1973-11-16

6.  Cation complexation by valinomycin- and nigericin-type inophores registered by the fluorescence signal of Tl+.

Authors:  G Cornelius; W Gärtner; D H Haynes
Journal:  Biochemistry       Date:  1974-07-16       Impact factor: 3.162

7.  Optical activity and conformation of the cation carrier X537A.

Authors:  S R Alpha; A H Brady
Journal:  J Am Chem Soc       Date:  1973-10-17       Impact factor: 15.419

8.  Biosynthesis of lasalocid. III. Isolation and structure determination of four homologs of lasalocid A.

Authors:  J W Westley; W Benz; J Donahue; R H Evans; C G Scott; A Stempel; J Berger
Journal:  J Antibiot (Tokyo)       Date:  1974-10       Impact factor: 2.649

9.  Biosynthesis of lasalocid. I. Incorporation of 13C and 14C labelled substrates into lasalocid A.

Authors:  J W Westley; R H Evans; G Harvey; R G Pitcher; D L Pruess
Journal:  J Antibiot (Tokyo)       Date:  1974-04       Impact factor: 2.649

10.  Biosynthesis of lasalocid. II. X-ray analysis of a naturally occurring isomer of lasalocid A.

Authors:  J W Westley; J F Blount; R H Evans; A Stempel; J Berger
Journal:  J Antibiot (Tokyo)       Date:  1974-08       Impact factor: 2.649

View more
  5 in total

1.  Formation of hybrid complexes between Ca and the ionophores bromolasalocid (Br-X537A) and A23187.

Authors:  M Deleers; M Gelbcke; W J Malaisse
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

2.  Conformational analysis of the calcium--A23187 complex at a lipid--water interface.

Authors:  R Brasseur; M Deleers; W J Malaisse; J M Ruysschaert
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

3.  Biogenic amine-ionophore interactions: Structure and dynamics of lasalocid (X537A) complexes with phenethylamines and catecholamines in nonpolar solution.

Authors:  C Shen; D J Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

4.  Free acid, anion, alkali, and alkaline earth complexes of lasalocid a (X537A) in methanol: structural and kinetic studies at the monomer level.

Authors:  C Shen; D J Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

5.  Modification of plant cell wall structure accompanied by enhancement of saccharification efficiency using a chemical, lasalocid sodium.

Authors:  Emiko Okubo-Kurihara; Misato Ohtani; Yukio Kurihara; Koichi Kakegawa; Megumi Kobayashi; Noriko Nagata; Takanori Komatsu; Jun Kikuchi; Sean Cutler; Taku Demura; Minami Matsui
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.